chr19-1104839-C-CA
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate
The NM_002085.5(GPX4):c.85-346dup variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000128 in 1,097,590 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
GPX4
NM_002085.5 intron
NM_002085.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -2.82
Genes affected
GPX4 (HGNC:4556): (glutathione peroxidase 4) The protein encoded by this gene belongs to the glutathione peroxidase family, members of which catalyze the reduction of hydrogen peroxide, organic hydroperoxides and lipid hydroperoxides, and thereby protect cells against oxidative damage. Several isozymes of this gene family exist in vertebrates, which vary in cellular location and substrate specificity. This isozyme has a high preference for lipid hydroperoxides and protects cells against membrane lipid peroxidation and cell death. It is also required for normal sperm development; thus, it has been identified as a 'moonlighting' protein because of its ability to serve dual functions as a peroxidase, as well as a structural protein in mature spermatozoa. Mutations in this gene are associated with Sedaghatian type of spondylometaphyseal dysplasia (SMDS). This isozyme is also a selenoprotein, containing the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Transcript variants resulting from alternative splicing or use of alternate promoters have been described to encode isoforms with different subcellular localization. [provided by RefSeq, Dec 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-1104839-C-CA is Pathogenic according to our data. Variant chr19-1104839-C-CA is described in ClinVar as [Pathogenic]. Clinvar id is 2056682.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPX4 | NM_002085.5 | c.85-346dup | intron_variant | ENST00000354171.13 | NP_002076.2 | |||
GPX4 | NM_001039848.4 | c.106dup | p.Arg36LysfsTer57 | frameshift_variant | 1/7 | NP_001034937.1 | ||
GPX4 | NM_001039847.3 | c.85-346dup | intron_variant | NP_001034936.1 | ||||
GPX4 | NM_001367832.1 | c.4-346dup | intron_variant | NP_001354761.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPX4 | ENST00000354171.13 | c.85-346dup | intron_variant | 1 | NM_002085.5 | ENSP00000346103 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151798Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
151798
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000122 AC: 1AN: 82136Hom.: 0 AF XY: 0.0000213 AC XY: 1AN XY: 46954
GnomAD3 exomes
AF:
AC:
1
AN:
82136
Hom.:
AF XY:
AC XY:
1
AN XY:
46954
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000116 AC: 11AN: 945792Hom.: 0 Cov.: 30 AF XY: 0.0000112 AC XY: 5AN XY: 447170
GnomAD4 exome
AF:
AC:
11
AN:
945792
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
447170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151798Hom.: 0 Cov.: 33 AF XY: 0.0000270 AC XY: 2AN XY: 74142
GnomAD4 genome
AF:
AC:
3
AN:
151798
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74142
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 05, 2022 | This sequence change creates a premature translational stop signal (p.Arg36Lysfs*57) in the GPX4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GPX4 are known to be pathogenic (PMID: 24706940). This variant is present in population databases (rs774824204, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with GPX4-related conditions. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at